Cargando…
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Schizophrenia is a debilitating illness with a lifetime prevalence estimate of 0.6% and consists of symptoms from the positive, negative, and cognitive domains. Social support, therapy, psychoeducation, and overall case management are very important aspects of the treatment of schizophrenia. However...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318953/ https://www.ncbi.nlm.nih.gov/pubmed/34196945 http://dx.doi.org/10.1007/s40265-021-01556-4 |